ロード中...
Precision Medicines’ Impact on Orphan Drug Designation
The incentives provided under the Orphan Drug Act (ODA) have been credited for catalyzing the marketing approval of drugs for the treatment of rare diseases by the US Food and Drug Administration. Orphan drug designation, the granting of special status to drugs or biologics (“drugs”) for the treatme...
保存先:
| 出版年: | Clin Transl Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853264/ https://ncbi.nlm.nih.gov/pubmed/31297924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12667 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|